Precigen, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PGEN research report →
About the company
Precigen, Inc. is an American company dedicated to the discovery and development of cutting-edge gene and cellular therapies. The company also offers disease-modifying treatments, genetically engineered swine for regenerative medicine, and advanced reproductive and embryo transfer technologies.
- CEO
- Helen Sabzevari
- IPO
- 2013
- Employees
- 143
- HQ
- Germantown, MD, US
Price Chart
- Market Cap
- $1.69B
- P/E
- -4.40
- P/S
- 53.63
- P/B
- 87.24
- EV/EBITDA
- -9.15
- Div Yield
- 0.00%
- Gross Margin
- 75.63%
- Op Margin
- -297.21%
- Net Margin
- -646.99%
- ROE
- -1768.51%
- ROIC
- -79.18%
- Revenue
- $9.68M · 146.73%
- Net Income
- $-250,642,000 · -98.55%
- EPS
- $-1.41 · -200.00%
- Op Income
- $-106,600,000
- FCF YoY
- -17.03%
- 52W High
- $6.04
- 52W Low
- $1.47
- 50D MA
- $4.44
- 200D MA
- $4.09
- Beta
- 1.00
- Avg Volume
- 4.37M
Get TickerSpark's AI analysis on PGEN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 29, 26 | Thomasian Harry Jr. | sell | 28,571 |
| Jul 1, 26 | Thomasian Harry Jr. | sell | 171,429 |
| Jun 29, 26 | Shah Rutul R | other | 42,924 |
| Jun 29, 26 | Shah Rutul R | sell | 42,924 |
| Jun 29, 26 | Shah Rutul R | other | 42,924 |
| Jun 29, 26 | Sabzevari Helen | other | 346,836 |
| Jun 29, 26 | Sabzevari Helen | sell | 346,836 |
| Jun 29, 26 | Sabzevari Helen | other | 346,836 |
| May 28, 26 | Thomasian Harry Jr. | sell | 41,884 |
| May 28, 26 | Tennant Phil | sell | 30,272 |
Our PGEN coverage
Recent articles, reports, and earnings notes.
No research on PGEN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PGEN report →Similar companies
Peers in the same neighborhood.